Loading...

bioMérieux S.A.

BMXMFPNK
HealthcareMedical - Diagnostics & Research
$136.00
$1.75(1.30%)

bioMérieux S.A. (BMXMF) Company Profile & Overview

Explore bioMérieux S.A.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

bioMérieux S.A. (BMXMF) Company Profile & Overview

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOMr. Pierre Boulud

Contact Information

33 4 78 87 20 00
376 Chemin De l’Orme, Marcy l'Étoile, 69280

Company Facts

14,147 Employees
IPO DateSep 21, 2017
CountryFR
Actively Trading

Frequently Asked Questions